NCT03520790 2025-03-21Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic CancerDana-Farber Cancer InstitutePhase 1 Terminated36 enrolled
NCT03300921 2022-03-31A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic CancerAbramson Cancer Center at Penn MedicinePhase 1 Terminated3 enrolled